Aclys Bio Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 3

Aclys Bio General Information

Description

Developer of precision biologics designed for the treatment of cancer. The company identifies a set of novel precision and immune-oncology targets from the tumour molecular profiles of tens of thousands of cancer patients and is building antibody-based therapies against each target, both for internal development and for partnership, enabling clinicians to decrease clinical trial times, costs, and risk, while improving trial success rates and ultimately, patient lives.

Contact Information

Website
www.aclys.bio
Formerly Known As
Javelin Oncology
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 16 Cavendish Court
  • Suite 408
  • Lebanon, NH 03766
  • United States
+1 (603)
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 16 Cavendish Court
  • Suite 408
  • Lebanon, NH 03766
  • United States
+1 (603)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aclys Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private Completed Pre-Clinical Trials
4. Accelerator/Incubator Completed Pre-Clinical Trials
3. Grant 01-Jul-2022 Completed Pre-Clinical Trials
2. Seed Round 10-Dec-2019 $1.5M $1.5M Completed Pre-Clinical Trials
1. Grant 10-May-2019 $294K Completed Pre-Clinical Trials
To view Aclys Bio’s complete valuation and funding history, request access »

Aclys Bio Patents

Aclys Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023215746-A2 Anti-alppl2 antibodies and chimeric antigen receptors, and compositions and methods of use Inactive 02-May-2022
WO-2023215746-A3 Anti-alppl2 antibodies and chimeric antigen receptors, and compositions and methods of use Inactive 02-May-2022
WO-2023215746-A9 Anti-alppl2 antibodies and chimeric antigen receptors, and compositions and methods of use Inactive 02-May-2022
JP-2025066746-A Anti adam12 antibody and chimeric antigen receptor, and composition and method including the same Pending 20-Mar-2019
CA-3133633-A1 Anti-adam12 antibodies and chimeric antigen receptors, and compositions and methods comprising Pending 20-Mar-2019 C07K16/40
To view Aclys Bio’s complete patent history, request access »

Aclys Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aclys Bio Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
National Cancer Institute Government
DRIVEN Accelerator Hub Accelerator/Incubator
To view Aclys Bio’s complete investors history, request access »

Aclys Bio FAQs

  • When was Aclys Bio founded?

    Aclys Bio was founded in 2017.

  • Where is Aclys Bio headquartered?

    Aclys Bio is headquartered in Lebanon, NH.

  • What is the size of Aclys Bio?

    Aclys Bio has 2 total employees.

  • What industry is Aclys Bio in?

    Aclys Bio’s primary industry is Biotechnology.

  • Is Aclys Bio a private or public company?

    Aclys Bio is a Private company.

  • What is Aclys Bio’s current revenue?

    The current revenue for Aclys Bio is .

  • How much funding has Aclys Bio raised over time?

    Aclys Bio has raised $1.5M.

  • Who are Aclys Bio’s investors?

    National Institutes of Health, National Cancer Institute, and DRIVEN Accelerator Hub have invested in Aclys Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process